Chemed Corporation CHE
Set alert
534.72 USD -7.20 -1.33%
At close · Oct 30
534.73 +0.01 +0.00%
After hours · Oct 30, 6:14 PM ET
533.25 Day range 550.93
368.59 52-week range 552.72
- YTD
- +24.98%
- 1 year
- +17.67%
- Open
- 545.01
- Prev close
- 541.92
- Mkt cap
- 6.93B
- Vol
- 180.47K
- Avg vol
- 154.34K
- EPS
- 20.88
- P/E
- 25.61
- Div yield
- 0.52%
More statistics
- Low
- 533.25
- High
- 550.93
- Forward P/E
- 19.45
- Beta
- 0.51
- Short ratio
- 4.25
- Inst. own
- 105.43%
- Dividend
- 2.80
- Ex-div date
- Aug 16, 2026
- Earnings
- Feb 24, 2027
- 50-d avg
- 514.74
- 200-d avg
- 462.35
- 1y target
- 617.00
1Y chart
Events in this range
- Nov 17, 2025Dividend: 0.6
- Feb 23, 2026Dividend: 0.6
- Feb 25, 2026Earnings: 6.42; estimate 7.02; surprise -8.55%
- Apr 23, 2026Earnings: 5.65; estimate 5.3; surprise 6.6%
- May 28, 2026Dividend: 0.6
- Jul 28, 2026Earnings: 6.06; estimate 5.6; surprise 8.21%
- Jul 31, 2026Rating: Oppenheimer · Outperform → Outperform
- Aug 17, 2026Dividend: 0.7
- Sep 25, 2026Rating: UBS · — → Buy
- Oct 27, 2026Earnings: 6.75; estimate 6.44; surprise 4.81%
- Oct 28, 2026Rating: Jefferies · Hold → Buy
- Oct 29, 2026Rating: Oppenheimer · Outperform → Outperform
- Oct 29, 2026Rating: UBS · Buy → Buy
- Oct 29, 2026Rating: RBC Capital · Sector Perform → Sector Perform
Signals (56)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 4 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| RSI: Oversold | Mar 20, 2026 | 7 months ago |
| RSI: Oversold | Mar 18, 2026 | 7 months ago |
| SMA: Bearish | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 26, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| RSI: Oversold | Feb 26, 2026 | 8 months ago |
| SMA: Bullish | Feb 19, 2026 | 8 months ago |
| SMA: Bearish | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 4, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bearish | Nov 28, 2025 | 11 months ago |
| SMA: Bullish | Nov 26, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 14, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 6, 2025 | 12 months ago |
| SMA: Bearish | Oct 31, 2025 | 1 year ago |
Key statistics
- Market cap
- 7.02B
- Enterprise value
- 7.42B
- Trailing P/E
- 25.95
- Forward P/E
- 19.45
- PEG ratio
- 1.98
- Price / sales
- 2.64
- Price / book
- 8.21
- EPS (TTM)
- 20.88
- Beta
- 0.51
- Dividend yield
- 0.52%
- Payout ratio
- 12.07%
- Profit margin
- 10.61%
- Revenue (TTM)
- 2.66B
- Revenue growth
- 10.60%
- Free cash flow
- 262.60M
- Total cash
- 48.43M
- Total debt
- 392.19M
- Return on equity
- 29.14%
- Shares outstanding
- 12.96M
- Short % of float
- 6.24%
- 50-day average
- 514.74
- 200-day average
- 462.35
Analyst view
Consensus: buy
Buy
Price target (mean) 617.00 +15.4% upside
Now 534.72
- Target (low)
- 580.00
- Target (mean)
- 617.00
- Target (high)
- 675.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 7.35.
Financials — quick view
CHE Revenue — quarterly 690.94M
CHE Net income — quarterly 71.65M
CHE EPS — quarterly 5.49
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 7.32 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | 6.44 | 6.75 | +0.31 | +4.81% |
| Jul 28, 2026 | Jun 30, 2026 | 5.60 | 6.06 | +0.46 | +8.21% |
| Apr 23, 2026 | Mar 31, 2026 | 5.30 | 5.65 | +0.35 | +6.60% |
| Feb 25, 2026 | Dec 31, 2025 | 7.02 | 6.42 | -0.60 | -8.55% |
| Oct 28, 2025 | Sep 30, 2025 | 5.39 | 5.27 | -0.12 | -2.23% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Oct 29, 2026 | UBS | main | Buy | Buy |
| Oct 29, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 28, 2026 | Jefferies | up | Hold | Buy |
| Sep 25, 2026 | UBS | init | — | Buy |
| Jul 31, 2026 | Oppenheimer | main | Outperform | Outperform |
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- chemed.com
News
- RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $585
- Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625
- What Chemed (CHE) Said on Its Q3 Earnings Call
- Jefferies Upgrades Chemed to Buy, Raises Price Target to $620
- Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript
- Chemed Q3 2026 Earnings Call Transcript
- Here Are Wednesday’s Top Wall Street Analyst Research Calls: Enphase Energy, F5, Marvell Technology, MSG Rangers, Pentair, Silicon Motion Technology, Spotify Technology, Texas Instruments, Whirlpool, and More
- Chemed (CHE) Tops Q3 Earnings and Revenue Estimates
- Chemed Reports Third-Quarter 2026 Results
- Chemed (CHE) Set to Release Quarterly Earnings on Tuesday
Your note
Sign in to keep a note on CHE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DELYONS RON | Director | Stock Award(Grant) | May 17, 2026 | 2,052 |
| GRACE PATRICK P | Director | Sale | Jul 30, 2026 | 3,533 |
| HEANEY CHRISTOPHER J | Director | Stock Award(Grant) | May 17, 2026 | 2,775 |
| HUTTON THOMAS CHARLES | Officer and Director | Conversion of Exercise of derivative security | Sep 27, 2026 | 32,840 |
| JUDKINS BRIAN C | Officer | Conversion of Exercise of derivative security | Aug 9, 2026 | 3,344 |
| LEE SPENCER S | Officer | Conversion of Exercise of derivative security | Sep 29, 2026 | 14,851 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.36% | 1,484,282 | 804.12M | Jun 29, 2026 |
| AQR Capital Management, LLC | 7.44% | 972,474 | 526.85M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.02% | 787,068 | 426.40M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.62% | 604,420 | 327.45M | Jun 29, 2026 |
| Acadian Asset Management. LLC | 3.47% | 453,238 | 245.55M | Jun 29, 2026 |
| State Street Corporation | 3.40% | 444,716 | 240.93M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 465,608 | 252.25M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.26% | 426,035 | 230.81M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.35% | 307,739 | 166.72M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.93% | 251,878 | 136.46M | Aug 30, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 1.61% | 210,584 | 114.09M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.35% | 176,971 | 95.88M | Jun 29, 2026 |